Publications:

1. Carter BL, Lund BC, Hayase N, Chrischilles EA. A longitudinal analysis of antihypertensive drug interactions in a Medicaid population. American Journal of Hypertension 2004;17:421-7.
2. 51Zillich AJ, McDonough RP, Carter BL, Doucette WR. Influential characteristics of physician/pharmacist collaborative relationships. The Annals of Pharmacotherapy 2004;38:764-70.
3. 52Chrischilles EA, Carter BL, Lund BC, Rubenstein LM, Chen-Hardee SS, Voelker MD, Park TR, Kuehl AK. Evaluation of the Iowa Medicaid Pharmaceutical Case Management program. J Am Pharm Assoc. 2004;44:337-49.
4. Zillich AJ, Doucette WR, Carter BL, Kreiter CD.  Development and initial validation of an instrument to measure physician-pharmacist collaboration from the physician perspective. Value in Health 2005;8:59-66.
5. Zillich AJ, Sutherland JM, Kumbera PA, Carter BL. Hypertension Outcomes through blood pressure monitoring and evaluation by pharmacists (Home Study). Journal of General Internal Medicine 2005;20:1091-6.
6. Carter BL, Hartz A, Bergus G et al. Relationship between physician knowledge of hypertension and blood pressure control. Journal of Clinical Hypertension 2006;8:481-486.
7. Ernst ME, Carter BL, Goerdt CJ et al. Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure. Hypertension 2006;47:352-358. 
8. Milchak JL, Carter BL, Ardery G et al. Development of explicit criteria to measure adherence to hypertension guidelines. Journal of Human Hypertension 2006;20:426-33.
9. Zillich AJ, Milchak JL, Carter BL, Doucette WR. Utility of a questionnaire to measure physician-pharmacist collaborative relationships. J Am Pharm Assoc 2006;46:453-458.
10. Zillich AJ, Garg J, Basu S, Bakris GL , Carter BL . Thiazide diuretics, potassium, and the development of diabetes: A quantitative review. Hypertension 2006;48:219-224.
11. Ardery G, Carter BL, Milchak JL et al. Explicit and implicit evaluation of physician adherence to hypertension guidelines. Journal of Clinical Hypertension 2007;9:113-119.
12. Hoth AB, Carter BL, Ness J et al. Development and reliability testing of the clinical pharmacist recommendation taxonomy. Pharmacotherapy 2007;27:639-646.
13. Kaboli PJ, Ahivapour DM, Henderson MS, Barnett JM, Ishani A, Carter BL. Patient and provider perceptions of hypertension treatment: Do they agree? Journal of Clinical Hypertension 2007;9:416-423.
14. Dickerson LM, Kraus CK, Kuo GM et al. Formation of a primary care pharmacist practice-based research network. Am J Health-Syst Pharm. 2007;64:2004-09.
15. Ascione F, Bero L, Carter B, Malone D, Schommer J, Schumock G, Vermeulen L, Welage L.  IOM Roundtable on Evidence-Based Medicine Sectoral Strategy:  Health Professional Sector-Pharmacy Subsector.  Prepared for IOM, 2007.
16. Von Muenster SJ, Carter BL, Weber CA et al. Description of pharmacist interventions during physician-pharmacist co-management of hypertension.  Pharmacy World & Science 2008:30:128-135.
17. Carter BL, Bergus GR, Dawson et al. A cluster-randomized trial to evaluate physician\pharmacist collaboration to improve blood pressure control. Journal of Clinical Hypertension 2008;10:260-271.
18. Weber CA, Leloux MR, Carter BL et al. Reduction in adverse symptoms once blood pressure is controlled.  Pharmacotherapy (in press 2008).
19. Milchak JL, Carter BL, Ardery G et al. Guideline adherence and blood pressure control in elders. Pharmacotherapy (in press 2008).
20. Ernst ME, Weber CA, Dawson JD, O'Connor MA, Carter BL, Bergus GR. How well does a shortened time interval characterize results of a full ambulatory blood pressure monitoring session? Journal of Clinical Hypertension (in press 2008).
21. Carter BL, Farris K, Abramowitz P et al. The Iowa Continuity of Care Study: Background and Methods. Amer J Health-System Pharm. (in press 2008).